<
New trends in the biomedical capital market: reverse acquisition of war IPO
Release time: 2016-10-10 & nbsp & nbsp & nbsp Source: Anonymous
  IPO (the first public fundraising) refers to the first time a company or company (a joint -stock company) sold its shares to the public,Compared My stake betting appwith stake online sports bettinggeneral enterprises,The biggest advantage of listed companies is that they can raise funds on a large scale in the securities market,To promote the rapid growth of the company's scale。
 
  Lystronomy,Also called & ldquo; reverse acquisition & rdquo;,refers to the parent company (group company) of the listed company (group company) through injection of the main assets into the listed subsidiary,To realize the listing of the parent company,One of the typical cases of backdoor listing is Johnson & ldquo; mother & rdquo; borrow & ldquo; Zi & rdquo; shell。
 
  So,Listing qualifications for listed companies have become a kind of rare resource & rdquo;,The so -called & ldquo; shell & rdquo; refers to the listing qualification of listed companies。
 
  & ldquo; reverse acquisition & rdquo; Stake Sports Bettingnew stake online sports bettingtrend in the biomedical capital market
 
  Despite some signs that the IPO of the biomedical market in 2017 seems to be up again,But the pharmaceutical companies have begun to adopt a more pragmatic attitude towards the backdoor listing。
 
   & ldquo; reverse acquisition & rdquo; phenomenon,In 2016, it seems to be a Stake Sports Bettingnew stake online sports bettingtrend in the biomedical capital market。Generally speaking,The existing shell company may be empty with funds without specific projects or products,By reverse acquisition,After the merger of the two companies, more funds may be raised。
 
  According to statistics,As of now,4-5 biomedical companies in the US stock market have completed reverse acquisitions (backdoor),And this number will further increase in the remaining few months this year。Similar situations also occur on the body of the tumor research and development company Medivation and PUMA biotechnology company。
 
  Analysts and even expected,These successful cases will also stimulate the wind direction of the backdoor listing in the biomedical industry,20%-25%of the biomedical companies that log in to the stock market in the last IPO tide will become the goal of potential backdoor listing in the future。
 
  Biomedical IPO still maintains a certain heat
 
  Biomedical IPO still seems to maintain a certain heat this year。So far, 20 biomedical companies stake sports betting apphave My stake betting appcompleted the IPO,Late this year,AC Immunes of neurodegenerative disease research companies and non -biological preparations Azurrx Biopharma and NOVAN will test the water one after another,Prove that the IPO of the biomedical industry is still。
 
  It is expected,The number of biomedical IPOs will reach 30 at the end of the year,This also made the first five (six) column of the number of IPO companies in the past 20 years in 2016,Some analysts believe that more biomedical companies will join the IPO in the first half of 2017。